BSEKerala Ayurveda LtdHighNeutral
Announced Mon, 25 May · 20:01 IST

Financial Results for the Year Ended 31st March 2026

Revenue Growth 20pctPat NegativeEmphasis Of MatterNegative Operating CashflowResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.6%1-day move
₹211.40
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.6-8.6-11.6-15.6-17.0-15.8-12.5-13.0-26.1
Up moveDown movePending
AI summary

Kerala Ayurveda Limited reported annual total income of Rs 10,341.97 lakhs for FY26 (standalone), up 32.8% from Rs 7,786.05 lakhs in FY25. However, the company continues to incur significant losses with standalone PAT of Rs -1,496.15 lakhs (vs Rs -1,387.69 lakhs in FY25). Consolidated total income was Rs 14,535.69 lakhs with consolidated PAT of Rs -2,041.47 lakhs. The auditors issued an unmodified (clean) opinion. The audit report contains an Emphasis of Matter noting significant trade receivables due from subsidiaries outstanding for more than 6 months, with no provision for expected credit loss made despite the age of these balances. The company has 8 subsidiaries including overseas entities in USA and Singapore.

Likely market impact

Revenue growth is positive but widening losses and negative operating cash flow of Rs -2,505 lakhs (standalone) indicate cash burn concerns. The Emphasis of Matter on recoverable receivables from subsidiaries adds risk. Shareholders should monitor if the company can achieve profitability and positive cash flows.